Kapil Bhutada | Senior Director, Safety Operations and Compliance, Medical Safety & Pharmacovigilance
AskBio

Kapil Bhutada is Head of Medical Safety & Pharmacovigilance at Asklepios BioPharmaceutical (AskBio), a Bayer AG subsidiary developing AAV gene therapies. He leads pharmacovigilance operations, compliance, and DMC activities across a multi-program clinical portfolio spanning cardiology, neuromuscular, and neurodegenerative diseases, including congestive heart failure, limb-girdle muscular dystrophy, Parkinson's disease, multiple system atrophy, Pompe disease, and Danon disease. His remit covers safety governance, signal management, DSMB/DMC strategy, regulatory submissions, CRO oversight, and inspection readiness. With more than 17 years in drug safety, Kapil has held pharmacovigilance roles at Genzyme/Sanofi, Cubist/Merck, Alkermes, and Medicago.  He has co-authored publications in leading medical journals and has spoken at the World Drug Safety Congress Americas. Kapil holds a Master's in Regulatory Affairs from Northeastern University and a Bachelor in  Pharmacy.